Nephros to Present at the Virtual Summer Summit
Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from investors.
SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting at the upcoming Virtual Summer Summit on Tuesday, June 9th at 10:55 AM ET. Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from investors.
You can access the webcast presentation at the following link: HERE
For more information and to register to attend or request a 1/1 virtual call click: HERE
About Nephros
Nephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets.
Nephros ultrafilters are used in hospitals, medical clinics, and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks, and ice machines. Nephros ultrafilters are also used in dialysis centers to aid in the removal of endotoxins and other biological contaminants from water and bicarbonate concentrate in hemodialysis machines.
Nephros pathogen detection systems, including the PluraPath™ system, provide real-time data on waterborne bacteria and virus content to medical and water quality professionals. Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information within an hour.
Nephros commercial filters, including AETHER™ brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.
For more information about Nephros, please visit its website at www.nephros.com.
Contacts:
Investor Relations:
Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
[email protected]
www.pcgadvisory.com
Media Relations:
Bill Douglass
Gotham Communications, LLC
(646) 504-0890
[email protected]
www.gothamcomm.com
Company:
Andy Astor, COO & CFO
Nephros, Inc.
(201) 345-0824
[email protected]
www.nephros.com
